Abstract
There are few clinical data describing the relative risks of extrapyramidal symptoms (EPS) at higher doses of ziprasidone (i.e., greater than 160 mg/day) when compared to lower doses. We report on a patient who displayed no EPS with ziprasidone 160 mg/day for several months, but did display marked, acute dystonic reactions on ziprasidone 240 mg/day. The observations from the present case indicate that high-dose, ziprasidone-induced acute dystonia may occur even if no such side effects have been experienced at doses up to and including 160 mg/day.
Original language | English |
---|---|
Pages (from-to) | 546-547 |
Number of pages | 2 |
Journal | Progress in Neuro-Psychopharmacology and Biological Psychiatry |
Volume | 31 |
Issue number | 2 |
DOIs | |
State | Published - 30 Mar 2007 |
Externally published | Yes |
Keywords
- Acute dystonia
- Extrapyramidal symptoms (EPS)
- High-dose
- Schizophrenia
- Side effects
- Ziprasidone